The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 12, 2019

Filed:

May. 08, 2015
Applicant:

The Johns Hopkins University, Baltimore, MD (US);

Inventors:

William G. Nelson, Towson, MD (US);

Srinivasan Yegnasubramanian, Baltimore, MD (US);

Xiaohui Lin, Redlands, CA (US);

Traci J. Speed, Baltimore, MD (US);

Zachery Reichert, Baltimore, MD (US);

Assignee:

The Johns Hopkins University, Baltimore, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/444 (2006.01); A61K 31/404 (2006.01); A61K 31/4188 (2006.01); A61K 31/381 (2006.01); A61K 31/4439 (2006.01); C12Q 1/6886 (2018.01); A61K 31/4245 (2006.01); A61K 31/433 (2006.01); A61K 31/136 (2006.01); A61K 31/517 (2006.01); A61K 31/519 (2006.01); G01N 33/68 (2006.01); G01N 33/50 (2006.01); A61K 31/4184 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); A61K 31/136 (2013.01); A61K 31/381 (2013.01); A61K 31/404 (2013.01); A61K 31/4184 (2013.01); A61K 31/4188 (2013.01); A61K 31/4245 (2013.01); A61K 31/433 (2013.01); A61K 31/444 (2013.01); A61K 31/4439 (2013.01); A61K 31/517 (2013.01); A61K 31/519 (2013.01); G01N 33/5011 (2013.01); G01N 33/6875 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/154 (2013.01); C12Q 2600/158 (2013.01); G01N 2500/00 (2013.01);
Abstract

The present invention provides methods for discovering agents that are effective in reversing epigenetic silencing by inhibiting the interaction of methyl-binding (MBD) proteins with methylated genomic DNA. Also provided are methods for reactivating silenced genes having CpG island hypermethylation along with methods for treatment and prevention of diseases, such as cancer and sickle cell anemia, by administering an agent that modulates methyl-binding domain (MBD) protein-mediated transcriptional repression, thereby increasing gene transcription to prevent or treat disease. Additionally, compounds identified by the present invention useful for treatment and prevention of diseases, such as cancer and sickle cell anemia, are provided.


Find Patent Forward Citations

Loading…